838
This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of pulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of etanercept therapy.
 four patients with rheumatoid arthritis: Subject; four: Subject.Population; developed new onset of pulmonary signs and symptoms with alveolar infiltrates: Effect; institution of etanercept therapy: Treatment; etanercept: Treatment.Drug; rheumatoid arthritis: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 four patients with rheumatoid arthritis: Subject; four: Subject.Population; developed new onset of pulmonary signs and symptoms with alveolar infiltrates: Effect; institution of etanercept therapy: Treatment; etanercept: Treatment.Drug; rheumatoid arthritis: Treatment.Disorder